310 related articles for article (PubMed ID: 7001494)
1. Leucocyte migration inhibition test results during desensitization treatment of children with atopic asthma.
Sychłowy A
Pharmatherapeutica; 1980; 2(6):397-400. PubMed ID: 7001494
[TBL] [Abstract][Full Text] [Related]
2. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of mite asthma (author's transl)].
Kirsten D
Z Erkr Atmungsorgane; 1980; 155(1):120-4. PubMed ID: 7210736
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology, diagnosis and treatment of the house-dust-mite allergy in asthmatic children].
Cernelc VD; Bobinjec M; Cernelc S
Allerg Immunol (Leipz); 1974-1975; 20-21(1):1-6. PubMed ID: 4282821
[TBL] [Abstract][Full Text] [Related]
5. [Secondary and tertiary prevention of allergic asthma in children].
Rancé F; Deschildre A; Bidat E; Just J; Couderc L; Wanin S; Weiss L;
Rev Mal Respir; 2010 Dec; 27(10):1221-30. PubMed ID: 21163398
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of asthma caused by house-dust mites with a combination of intal and vaccine adsorbed on tyrosine].
Sychłowy A; Lukas A; Nowak W; Maruszewski W
Pediatr Pol; 1979 Nov; 54(11):1295-8. PubMed ID: 117423
[No Abstract] [Full Text] [Related]
7. [Efficacy of oral hyposensitization treatment in house dust mite allergy (author's transl)].
Urbanek R; Gehl R
Monatsschr Kinderheilkd; 1982 Mar; 130(3):150-2. PubMed ID: 7087973
[TBL] [Abstract][Full Text] [Related]
8. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
[TBL] [Abstract][Full Text] [Related]
9. [Leukocyte migration inhibition test in the allergological diagnosis of pollen-induced asthma and evaluation of the results of desensitization treatment].
Grzegorczyk J; Kałła M; Rozniecki J
Pol Tyg Lek; 1980 Jun; 35(24):909-11. PubMed ID: 7413514
[No Abstract] [Full Text] [Related]
10. Study of immunological changes after hyposensitization in house dust sensitive asthmatic children.
Hsieh KH
Ann Allergy; 1982 Jan; 48(1):25-31. PubMed ID: 6976764
[TBL] [Abstract][Full Text] [Related]
11. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD
Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
[TBL] [Abstract][Full Text] [Related]
13. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
14. [Leukocyte migration inhibition test in patients with pollen-induced asthma and the results of hyposensitization therapy with Pollinex].
Grzegorczyk J; Rozniecki J; Kałła M
Pneumonol Pol; 1984 Mar; 52(3):123-30. PubMed ID: 6427758
[No Abstract] [Full Text] [Related]
15. [Clinical significance of allergen specific immunotherapy in adult house-dust-mite-sensitive bronchial asthma: impact on disease severity and medical cost].
Nagata M; Tabe K; Yamamoto H; Sakamoto Y; Matsuo H
Arerugi; 1999 Dec; 48(12):1316-21. PubMed ID: 10666919
[TBL] [Abstract][Full Text] [Related]
16. [Predicting the clinical efficacy of house dust mite immunotherapy in bronchial asthmatics by multiple quantification analysis type II].
Soda R; Okada C; Takahashi K; Katagi S; Kanehiro A; Kimura G; Okamoto S; Tada S; Kimura I
Arerugi; 1993 Dec; 42(12):1771-5. PubMed ID: 8110037
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immune response during specific hyposensitization in atopic asthma patients.
Moniuszko T; Chyrek-Borowska S; Moniuszko C
Arch Immunol Ther Exp (Warsz); 1984; 32(4):375-80. PubMed ID: 6335958
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
19. A trial of house dust mite adsorbed on tyrosine in general practice.
Lees LJ
Br J Clin Pract; 1974 Oct; 28(10):343-46. PubMed ID: 4613367
[No Abstract] [Full Text] [Related]
20. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
